Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21993685 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Monoclonal Antibody (mAb) 216 With Chemotherapy in Adult Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia
Conditions: Leukemia, Lymphocytic;   Leukemia;   Acute Lymphocytic Leukemia
Interventions: Drug: MAb 216;   Drug: Vincristine

Indicates status has not been verified in more than two years